AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Thursday, June 18, 2020

In The News

SARS-CoV-2 testing options that screen for active illness or past infection have expanded rapidly over the last few months. As institutions craft guidelines on optimizing polymerase chain reaction (PCR) diagnostic tests and serology antibody tests, some labs have been developing their own testing and result reporting algorithms.
Emerging evidence suggests neurofilament light (NfL) might be important in predicting progression of multiple sclerosis (MS). A study in Neurology reported that MS patients with elevated levels of this nerve protein biomarker were 40% to 70% more likely than those with low levels of NfL to have worsening symptoms within…
Testing most women for subclinical hypothyroidism in the first trimester of pregnancy may contribute to overdiagnosis and overtreatment of this condition during and after pregnancy. Researchers concluded this after studying thyroid-stimulating hormone (TSH) testing patterns in nearly 190,000 women.

AACC Alert

Current guidelines use an “all or nothing” approach to modifying in vitro diagnostic (IVD) devices, which fails to reflect real-world situations in laboratories. No agreed-upon mechanisms exist to deem a modification as minor or insignificant or to verify its impact on accuracy, safety, or effectiveness, an opinion paper in Clinical…

Inside AACC

Since the earliest days of the SARS-CoV-2 pandemic, AACC has offered resources to the global lab community through its science and advocacy initiatives, journals and news publications, and education programs. These resources and more are conveniently available on an open access AACC page, Coronavirus Resources for Labs.

World View

Simply returning rapid results is not sufficient for implementing point-of-care testing (POCT) for cardiac biomarkers. A review article stresses the need for clinical labs, cardiologists, and emergency departments to collaborate on proper decision-making protocols to deliver cardiac biomarker results in a timely manner. “If you don’t do that, you don’t…